Table 3 Clinical manifestations of disease activity in patients with axial spondylarthritis and psoriatic arthritis before COVID-19
| Â | Axial spondylarthritis | Psoriatic arthritis | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Cases (n = 132) | Controls (n = 97) | p | Cases (n = 75) | Controls (n = 43) | p | |||||
n | % | n | % | n | % | n | % | |||
No disease activity | 45 | 34.1 | 27 | 27.8 | 0.314 | 23 | 30.7 | 14 | 32.6 | 0.831 |
Peripheral arthritis | 13 | 9.8 | 10 | 10.3 | 0.909 | 17 | 22.7 | 12 | 27.9 | 0.525 |
Inflammatory back pain | 43 | 32.6 | 49 | 50.5 | 0.006 | 6 | 8.0 | 3 | 7.0 | 0.840 |
Enthesitis | 13 | 9.8 | 11 | 11.3 | 0.716 | 5 | 6.7 | 1 | 2.3 | 0.414 |
Uveitis | 3 | 2.3 | 4 | 4.1 | 0.421 | – | – | – | – | – |
Dactylitis | – | – | – | – | – | 6 | 8.0 | 1 | 2.3 | 0.209 |
Psoriasis | – | – | – | – | – | 23 | 30.7 | 10 | 23.3 | 0.388 |
MDA | – | – | – | – | – | 33 | 54.1 | 17 | 47.2 | 0.513 |